Nishadil
Signup Signin
Delhi | 25°C (windy)
A Universal Weapon Against Breast Cancer: UCLA Scientists Unveil Groundbreaking Immunotherapy

A Universal Weapon Against Breast Cancer: UCLA Scientists Unveil Groundbreaking Immunotherapy
A Father's Heart-Wrenching Plea: 'Give My Son a Chance to Live!'

A Father's Heart-Wrenching Plea: 'Give My Son a Chance to Live!'
Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape

Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape
Bristol Myers Squibb's Abecma Delivers Breakthrough Results in Multiple Myeloma Study

Bristol Myers Squibb's Abecma Delivers Breakthrough Results in Multiple Myeloma Study
From Relapse to Remarkable Recovery: How AI and CAR T-Cell Therapy Gave a Farmer a New Lease on Life

From Relapse to Remarkable Recovery: How AI and CAR T-Cell Therapy Gave a Farmer a New Lease on Life
Cero Therapeutics' Cancer Drug Gets FDA Fast Track, Yet Stock Plummets: Unpacking the Market's Paradox

Cero Therapeutics' Cancer Drug Gets FDA Fast Track, Yet Stock Plummets: Unpacking the Market's Paradox
Cell Therapy Manufacturing Market Set to Skyrocket to $18.89 Billion by 2034, Fueled by Chronic Disease Epidemic and Biotech Advancements

Cell Therapy Manufacturing Market Set to Skyrocket to $18.89 Billion by 2034, Fueled by Chronic Disease Epidemic and Biotech Advancements
Sarcoma's Silent Threat: Unveiling Hope Through Early Detection and Revolutionary Therapies

Sarcoma's Silent Threat: Unveiling Hope Through Early Detection and Revolutionary Therapies
A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy
CARsgen Therapeutics Unveils Stellar 2025 Interim Achievements: A Deep Dive into Innovation and Growth

CARsgen Therapeutics Unveils Stellar 2025 Interim Achievements: A Deep Dive into Innovation and Growth
Load more..